Skip to main content
Registrieren
Springer Medizin
SUCHE
MENÜ 1 2 3 4
main-content
nach oben
Erschienen in:
Multiple Sklerose und andere autoimmune ZNS-Erkrankungen Kapitel lesen Erstes Kapitel lesen

2018 | OriginalPaper | Buchkapitel

7. Neurologische Komplikationen der Vaskulitiden

verfasst von: Torsten Witte, Elke Voß, Martin Stangel

Erschienen in: Autoimmunerkrankungen in der Neurologie

Verlag: Springer Berlin Heidelberg

Einloggen, um Zugang zu erhalten

Zusammenfassung

Vaskulitiden sind entzündliche Erkrankungen der Blutgefäße, die in primäre und sekundäre Formen unterteilt werden. Sekundäre Vaskulitiden treten im Rahmen anderer Grunderkrankungen auf, z. B. bei Kollagenosen oder rheumatoider Arthritis. Auch können sekundäre Vaskulitiden durch Medikamente, Infektionen oder Neoplasien verursacht werden. In diesem Kapitel werden nur die primären Vaskulitiden besprochen. Eine Einteilung der Vaskulitiden erfolgt unter anderem basierend auf histologischen Veränderungen, anhand immunologischer Marker sowie des Gefäßkalibers. Die primären Vaskulitiden werden nach der Chapel-Hill-Klassifikation eingeteilt, die zuletzt 2012 revidiert wurde.
Literatur
Akman-Demir G, Serdaroglu P, Tasçi B (1999) Clinical patterns of neurological involvement in Behçet’s disease: evaluation of 200 patients. The Neuro-Behçet Study Group. Brain 122:2171–2182 CrossRef
Alexander MD, Yuan C, Rutman A, Tirschwell DL, Palagallo G, Gandhi D, Sekhar LN, Mossa-Basha M (2016) High-resolution intracranial vessel wall imaging: imaging beyond the lumen. J Neurol Neurosurg Psychiatry 87(6):589–597 CrossRefPubMed
Alrawi A, Trobe JD, Blaivas M, Musch DC (1999) Brain biopsy in primary angiitis of the central nervous system. Neurology 53(4):858–860 CrossRefPubMed
Alreshaid AA, Powers WJ (2003) Prognosis of patients with suspected primary CNS angiitis and negative brain biopsy. Neurology 61(6):831–833 CrossRefPubMed
Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, Lie JT, Lightfoot RW Jr et al (1990) The American college of rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 33:1129–1134 CrossRef
Birnbaum J, Hellmann DB (2009) Primary angiitis of the central nervous system. Arch Neurol 66:704–709 CrossRefPubMed
Bley TA, Reinhard M, Hauenstein C, Markl M, Warnatz K, Hetzel A, Uhl M, Vaith P, Langer M (2008) Comparison of duplex sonography and high-resolution magnetic resonance imaging in the diagnosis of giant cell (temporal) arteritis. Arthritis Rheum 58:2574–2578 CrossRefPubMed
Boyev LR, Miller NR, Green WR (1999) Efficacy of unilateral versus bilateral temporal artery biopsies for the diagnosis of giant cell arteritis. Am J Ophthalmol 128:211–215 CrossRefPubMed
Calabrese LH, Mallek JA (1997) Primary angiitis of the central nervous system. Report of 8 cases, review of the literature, and proposal for diagnostic criteria. Medicine (Baltimore) 76:20–39
Dasgupta B et al (2012) 2012 provisional classification criteria for polymyalgia rheumatica: a European league against rheumatism/American college of rheumatology collaborative initiaitve. Ann Rheum Dis 71:484–492 CrossRefPubMed
Dejaco C et al (2015) 2015 recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Ann Rheum Dis 74:1799–1807 CrossRefPubMed
Demaerel P, De Ruyter N, Maes F, Velghe B, Wilms G (2004) Magnetic resonance angiography in suspected cerebral vasculitis. Eur Radiol 14(6):1005–1012 CrossRefPubMed
Ducros A (2012) Reversible cerebral vasoconstriktion syndrome. Lancet Neurol 11(10):906–917 CrossRefPubMed
Falk RJ, Hogan S, Carey TS, Jennette JC (1990) Clinical course of anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and systemic vasculitis. The Glomerular Disease Collaborative Network. Ann Intern Med 113:656–663 CrossRefPubMed
Gayraud M, Guillevin L, Toumelin P le, Cohen P, Lhote F, Casassus P, Jarrousse B, French Vasculitis Study Group (2001) Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients. Arthritis Rheum 44:666–675 CrossRefPubMed
Guillevin L, Lhote F, Sauvaget F et al (1994) Treatment of polyarteritis nodosa related to hepatitis B virus with interferon-alpha and plasma exchanges. Ann Rheum Dis 53:334–337 CrossRefPubMedPubMedCentral
Guillevin L, Lhote F, Gayraud M, Cohen P, Jarrousse B, Lortholary O, Thibult N, Casassus P (1996) Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients. Medicine (Baltimore) 75:17–28 CrossRef
Guillevin L, Lhote F, Gherardi R (1997) Polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: clinical aspects, neurologic manifestations, and treatment. Neurol Clin 15:865–886 CrossRefPubMed
Hajj-Ali RA, Calabrese LH (2009) Central nervous system vasculitis. Curr Opin Rheumatol 21(1):10–18 CrossRefPubMed
Holle JU, Gross WL, Latza U, Nölle B, Ambrosch P, Heller M, Fertmann R, Reinhold-Keller E (2011) Improved outcome in 445 patients with Wegener’s granulomatosis in a German vasculitis center over four decades. Arthritis Rheum 63:257–266 CrossRefPubMed
Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, Lie JT et al (1990) The American college of rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 33:1122–1128 CrossRefPubMed
International Study Group for Behçet’s Disease (1990) Criteria for diagnosis of Behçet’s Disease. Lancet 335:1078–1080
Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F et al (2013) 2012 revised international chapel hill consensus conference nomenclature of vasculitides. Arthritis Rheum 65(1):1–11 CrossRefPubMed
Kidd D, Steuer A, Denman AM, Rudge P (1999) Neurological complications in Behçet’s syndrome. Brain 122:2183–2194 CrossRefPubMed
Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP, Calabrese LH, Fries JF, Lie JT, Lightfoot RW Jr et al (1990) The American college of rheumatology 1990 criteria for the classification of Wegener’s granulomatosis. Arthritis Rheum 33:1101–1107 CrossRefPubMed
Lightfoot RW Jr, Michel BA, Bloch DA, Hunder GG, Zvaifler NJ, McShane DJ, Arend WP, Calabrese LH, Leavitt RY, Lie JT et al (1990) The American college of rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum 33:1088–1093 CrossRefPubMed
Masi AT, Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY et al (1990) The American college of rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 33:1094–1100 CrossRefPubMed
Miller DV, Salvarani C, Hunder GG, Brown RD, Parisi JE, Christianson TJ, Giannini C (2009) Biopsy findings in primary angiitis of the central nervous system. Am J Surg Pathol 33:35–43 CrossRefPubMed
Néel A, Pagnoux C (2009) Primary angiitis of the central nervous system. Clin Exp Rheumatol 27(1 Suppl 52):S95–107 PubMed
Park MC, Lee SW, Park YB, Chung NS, Lee SK (2005) Clinical characteristics and outcomes of Takayasu’s arteritis: analysis of 108 patients using standardized criteria for diagnosis, activity assessment, and angiographic classification. Scand J Rheumatol 34:284–292 CrossRefPubMed
Petursdottir V, Johansson H, Nordborg E, Nordborg C (1999) The epidemiology of biopsy-positive giant cell arteritis: special reference to cyclic fluctuations. Rheumatology 38:1208–12 CrossRefPubMed
Reinhold-Keller E, Herlyn K, Wagner-Bastmeyer R, Gross WL (2005) Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register. Arthritis Rheum 53:93–99 CrossRefPubMed
Salvarani C, Brown RD Jr, Christianson T, Miller DV, Giannini C, Huston J 3rd, Hunder GG (2015) An update of the Mayo Clinic cohort of patients with adult primary central nervous system vasculitis. Description of 163 patients. Medicine 94(21):e738 CrossRefPubMedPubMedCentral
Schmidt WA, Kraft HE, Vorpahl K, Völker L, Gromnica-Ihle EJ (1997) Color duplex ultrasonography in the diagnosis of temporal arteritis. N Engl J Med 337:1336–1342 CrossRefPubMed
Schmidt WA, Moll A, Seifert A, Schicke B, Gromnica-Ihle E, Krause A (2008) Prognosis of large-vessel giant cell arteritis. Rheumatology 47:1406–1408 CrossRefPubMed
Seror R, Mahr A, Ramanoelina J, Pagnoux C, Cohen P, Guillevin L (2006) Central nervous system involvement in Wegener granulomatosis. Medicine 85:54–65 CrossRef
Smeeth L, Cook C, Hall AJ (2006) Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990–2001. Ann Rheum Dis 65:1093–1098 CrossRefPubMedPubMedCentral
Stone JH, Pomper MG, Roubenoff R, Miller TJ, Hellmann DB (1994) Sensitivities of noninvasive tests for central nervous system vasculitis: a comparison of lumbar puncture, computed tomography, and magnetic resonance imaging. J Rheumatol 21(7):1277–1282 PubMed
Stone JH, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Turkiewicz A, Tchao NK, Webber L, Ding L, Sejismundo LP, Mieras K, Weitzenkamp D, Ikle D, Seyfert-Margolis V, Mueller M, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh KA, Kissin EY, Monach PA, Peikert T, Stegeman C, Ytterberg SR, Specks U, RAVE-ITN Research Group (2010) Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med 363:221–232 CrossRefPubMed
Torres J, Loomis C, Cucchiara B, Smith M, Messé S (2016) Diagnostic yield and safety of brain biopsy for suspected primary central nervous system angiitis. Stroke 47(8):2127–2129 CrossRefPubMed
Vital A, Vital C (2006) Neuromuscular biopsy and diagnosis of vasculitis. Ann Pathol 26:247–255 CrossRefPubMed
Weyland CM, Goronzy JJ (2014) Giant-cell arteritis and polymyalgia rheumatica. N Engl J Med 371:50–57 CrossRef
Wipfler-Freissmuth E, Moosig F, Schirmer M (2009) Recommendations of the European League Against Rheumatism (EULAR) for the treatment of „large-vessel vasculitides“. Z Rheumatol 68:260–263 CrossRefPubMed
Metadaten
Titel
Neurologische Komplikationen der Vaskulitiden
verfasst von
Torsten Witte
Elke Voß
Martin Stangel
Copyright-Jahr
2018
Verlag
Springer Berlin Heidelberg
Buch
Autoimmunerkrankungen in der Neurologie

Print ISBN: 978-3-662-55529-3

Electronic ISBN: 978-3-662-55530-9

Copyright-Jahr: 2018

DOI
https://doi.org/10.1007/978-3-662-55530-9_7

Neu in den Fachgebieten Neurologie und Psychiatrie

29.09.2022 | Long-COVID | Nachrichten

Nach Corona erhöhtes Risiko für neurologische Krankheiten

29.09.2022 | Morbus Alzheimer | Nachrichten

Neues Alzheimermedikament erfolgreich in Phase-3-Studie

27.09.2022 | Antidepressiva | Nachrichten

Keine Nachteile für Erwachsene mit Kindheitstraumata

25.09.2022 | Myasthenia gravis | Nachrichten

Erfolg mit Rituximab bei neu diagnostizierter Myasthenia gravis
» zur Themenseite Neurologie rotated-square
» zur Themenseite Psychiatrie rotated-square

Version: 0.2155.0